Logo image of OPK

OPKO HEALTH INC (OPK) Stock Fundamental Analysis

NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD

1.26  -0.01 (-0.79%)

After market: 1.27 +0.01 (+0.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OPK. OPK was compared to 102 industry peers in the Health Care Providers & Services industry. OPK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OPK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPK had negative earnings in the past year.
OPK had a negative operating cash flow in the past year.
In the past 5 years OPK reported 4 times negative net income.
In multiple years OPK reported negative operating cash flow during the last 5 years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

OPK has a Return On Assets of -1.83%. This is comparable to the rest of the industry: OPK outperforms 44.12% of its industry peers.
The Return On Equity of OPK (-2.97%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.83%
ROE -2.97%
ROIC N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

OPK's Gross Margin of 31.78% is in line compared to the rest of the industry. OPK outperforms 57.84% of its industry peers.
In the last couple of years the Gross Margin of OPK has declined.
The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPK has less shares outstanding
Compared to 5 years ago, OPK has more shares outstanding
The debt/assets ratio for OPK is higher compared to a year ago.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -0.51, we must say that OPK is in the distress zone and has some risk of bankruptcy.
OPK has a Altman-Z score of -0.51. This is amonst the worse of the industry: OPK underperforms 80.39% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that OPK is not too dependend on debt financing.
OPK has a Debt to Equity ratio of 0.25. This is in the better half of the industry: OPK outperforms 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -0.51
ROIC/WACCN/A
WACC8.08%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.49 indicates that OPK has no problem at all paying its short term obligations.
The Current ratio of OPK (2.49) is better than 85.29% of its industry peers.
OPK has a Quick Ratio of 2.28. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OPK (2.28) is better than 81.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 2.28
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.10% over the past year.
Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -13.78% in the last year.
Measured over the past years, OPK shows a decrease in Revenue. The Revenue has been decreasing by -4.59% on average per year.
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-13.78%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.7%

3.2 Future

OPK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.73% yearly.
Based on estimates for the next years, OPK will show a small growth in Revenue. The Revenue will grow by 7.69% on average per year.
EPS Next Y-71.77%
EPS Next 2Y-4.19%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.34%
Revenue Next 3Y5.25%
Revenue Next 5Y7.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPK. In the last year negative earnings were reported.
Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

OPK's earnings are expected to grow with 13.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.19%
EPS Next 3Y13.73%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (5/23/2025, 8:44:45 PM)

After market: 1.27 +0.01 (+0.79%)

1.26

-0.01 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners29.22%
Inst Owner Change23.14%
Ins Owners6.21%
Ins Owner Change0%
Market Cap999.24M
Analysts83.64
Price Target4.07 (223.02%)
Short Float %11.62%
Short Ratio6.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)33.11%
Min EPS beat(2)-44.39%
Max EPS beat(2)110.61%
EPS beat(4)3
Avg EPS beat(4)40.08%
Min EPS beat(4)-44.39%
Max EPS beat(4)110.61%
EPS beat(8)4
Avg EPS beat(8)23.63%
EPS beat(12)6
Avg EPS beat(12)-132.93%
EPS beat(16)7
Avg EPS beat(16)-133.51%
Revenue beat(2)1
Avg Revenue beat(2)3.66%
Min Revenue beat(2)-9.64%
Max Revenue beat(2)16.97%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)16.97%
Revenue beat(8)4
Avg Revenue beat(8)3.26%
Revenue beat(12)6
Avg Revenue beat(12)3.97%
Revenue beat(16)8
Avg Revenue beat(16)5.53%
PT rev (1m)0%
PT rev (3m)0.84%
EPS NQ rev (1m)-44.76%
EPS NQ rev (3m)-49.75%
EPS NY rev (1m)-18.39%
EPS NY rev (3m)-21.75%
Revenue NQ rev (1m)-1.66%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)-1.47%
Revenue NY rev (3m)-4.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 13.98
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.87
BVpS1.65
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.83%
ROE -2.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.78%
FCFM N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.79%
Cap/Sales 3.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 2.28
Altman-Z -0.51
F-Score4
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y-71.77%
EPS Next 2Y-4.19%
EPS Next 3Y13.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.78%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.7%
Revenue Next Year-4.69%
Revenue Next 2Y1.34%
Revenue Next 3Y5.25%
Revenue Next 5Y7.69%
EBIT growth 1Y-36.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.13%
EBIT Next 3Y32.69%
EBIT Next 5Y26.89%
FCF growth 1Y-71.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.39%
OCF growth 3YN/A
OCF growth 5YN/A